Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by α-synuclein immunocytochemistry

Neuroscience Letters

Volumn 265, Issue 1, 1999, Pages 67-69

  Braak, Heiko ^a   Sandmann Keil, Daniele ^a   Gai, Weiping ^b   Braak, Eva ^a  

^a GOETHE UNIVERSITY   (Germany)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Immunocytochemistry; Lewy bodies; Lewy neurites; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

AMYGDALOID NUCLEUS; ARTICLE; CELLULAR DISTRIBUTION; CYTOARCHITECTURE; HIPPOCAMPUS; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; NERVE CELL DEGENERATION; NEURITE; NEUROPATHOLOGY; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; VAGUS NERVE DORSAL NUCLEUS;

EID: 0033538002     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00208-6     Document Type: Article

References (17)

1. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M.Y., Trojanowski J.Q., Iwatsubo T. Aggregation of (-synuclein in Lewy Bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:1998;879-884.
2. Braak H., Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1:1991;213-216.
3. Braak H., Braak E., Yilmazer D., de Vos R.A.I., Jansen E.N.H., Bohl J., Jellinger K. Amygdala pathology in Parkinson's disease. Acta Neuropathol. 88:1994;493-500.
4. Braak H., Braak E., Yilmazer D., de Vos R.A.I., Jansen E.N.H., Bohl J. Pattern of brain destruction in Parkinson's and Alzheimer's diseases, J. Neural Transm., (PD Sect. 103:1996;455-490.
5. Dickson D.W., Ruan D., Crystal H., Mark M.H., Davies P., Kress Y., Yen S.H. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology. 41:1991;1402-1409.
6. Fearnley J., Lees A. Pathology of Parkinson's disease. Calne D.B. Neurodegenerative diseases. 1994;545 Saunders, Philadelphia.
7. Gibb W.R.G., Lees A.J. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol. Appl. Neurobiol. 15:1989;27-44.
8. Gibb W.R.G., Scott T., Lees A.J. Neuronal inclusions of Parkinson's disease. Mov. Disord. 6:1991;2-11.
9. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain (-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57:1998;334-337.
10. Jellinger K. Pathology of Parkinson's disease. Calne D.B. Handbook of Experimental Pharmacology, Drugs for the treatment of Parkinson's disease. 88:1989;47 Springer, Berlin.
11. Lowe J. Lewy bodies. Calne D.B. Neurodegenerative diseases. 1994;51 Saunders, Philadelphia.
12. Pollanen M.S., Dickson D.W., Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52:1993;183-191.
13. Spillantini M.G., Schmidt M.L., Lee V.M.Y., Trojanowski J.Q., Jakes R., Goedert M. (-Synuclein in Lewy bodies. Nature. 388:1997;839-840.
14. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. (-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA. 95:1998;6469-6473.
15. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/(-synuclein in neurodegenerative disorders. Am. J. Pathol. 152:1998;367-372.
16. Trojanowski J.Q., Lee V.M.Y. Aggregation of neurofilament and (-synuclein proteins in Lewy bodies - implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55:1998;151-152.
17. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease, Neurosci. Lett. 239:1997;45-48.